Updated Sep 1, 2026
Upgrade to a paid plan to see AI rating history on the chart.
WESTBROOK, Maine, August 31, 2026--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, P…
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOaEhFaG9ZeHdEMWxxQVJ5RWtJLW5yN2I2Uk5SUXFoelJLbEVHbFIta0Nxb01PQVJkV0ZGWmZET2lzNGhDQjlNM2JZM1ltNnJwM…
IDEXX Laboratories has struggled to keep pace with the broader market over the past year, but Wall Street still sees plenty of room for the stock to recover, w…
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPXzVyZlQ2X2toR1JUa2dRaktvRU9MSTZFTHU5aENxcEVWQUgwTEhZdVBWTWIzRVluaXlRSEFDYy1KQVBxaHhXVzRfcjNOcWhRR…
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPNFBWT2pvbnpub0owanMzZEJyclp3R3phQVZFT1VMVTFVeGM0bDNaOERleEdFUy0wRzhVZ1JSdjJJSklBTHR2ZVJqMWFHdUd2O…
IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and distributor inventory swings remain key risks.
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be download…
IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.
Not investment advice. Past performance does not guarantee future results. Full disclaimer